Fox Chase Cancer Center is the only National Cancer Institute–designated Comprehensive Cancer Center in the Philadelphia region dedicated solely to cancer. Fox Chase has a century-long tradition of important basic and clinical research, a distinction that includes two Nobel Prizes for its scientists. Fox Chase ranks among the top 20 cancer centers by U.S. News & World Report in its annual Best Hospitals listing.
Fox Chase’s nationally recognized physicians offer a full range of top-quality cancer programs for all types of adult cancers, including rare and difficult-to-treat tumors. The philosophy of care focuses on providing multidisciplinary treatment in an environment dedicated to caring for the whole person. The Center also maintains strong programs in cancer risk and prevention, minimally invasive surgery, urology, hematology-oncology, and women’s cancers.
In 2014, Fox Chase launched its Rapid Access Service, improving the region’s access to high-quality cancer care by offering patients next-business-day appointments with its experienced oncologists. At this time, Fox Chase is the only hospital in the region and one of a few in the nation offering these immediate appointments for cancer care. Fox Chase also recently launched its “Be the Breakthrough” initiative to increase awareness and understanding of clinical trials and to encourage greater discussion about theses studies between patients and providers. In the first six months of the program, clinical trial enrollment has increased by 60 percent.
In 2012, Fox Chase became a member of the Temple University Health System.
Name: Fox Chase Cancer Center
Location: Philadelphia, Pennsylvania